Austin, Texas, United States, October 2025 – Corey Collins has been appointed as Chief Executive Officer at Tekton Research, marking a pivotal milestone for the clinical research organization as it continues to expand its footprint across multiple therapeutic areas. Collins steps into the top leadership role after serving as President of the company, where he focused on driving business growth and operational excellence.
Collins joined Tekton Research in 2023 as Chief Financial Officer, where he played a central role in strengthening the company’s financial strategy and positioning Tekton for sustainable expansion. He was later elevated to President in early 2025, leading strategic initiatives and operational transformation that reinforced Tekton’s leadership in clinical research.
Prior to Tekton, Collins held senior leadership roles at American Expediting, where he served as President and Chief Financial Officer, and earlier as Chief Financial Officer. During his tenure, he helped drive operational efficiencies and strategic growth in a competitive logistics environment.
Before that, Collins was Chief Financial Officer at Dicalite Management Group, an international industrial minerals company, where he oversaw finance operations supporting a multi-mineral platform and diverse end-use industries. He also served as Vice President of FP&A and Commercial Finance at PCI Pharma Services, where he built centralized finance functions, supported multiple acquisitions across geographies, and delivered cost-saving digital analytics.
Collins spent over six years with GE Water & Process Technologies, where he progressed through finance leadership roles including Commercial Finance Director, Chemicals FP&A Leader, Assistant Global Controller, and North America Controller. His career began at Deloitte Consulting, where he worked as a Senior Consultant in Financial Management, followed by an Audit Senior role in Philadelphia, gaining deep expertise in finance operations, acquisition integration, and ERP alignment.
About Tekton Research
Founded in 2006, Tekton Research is a leading multi-state clinical research site network conducting Phase 2–4 clinical trials across therapeutic areas including neurology, psychiatry, cardiometabolic health, general medicine, infectious disease, and pediatrics. With 30+ leading investigators and more than 900 trials conducted, Tekton partners with sponsors, CROs, and biopharma companies to accelerate drug development while upholding patient-centered care. Supported by experienced clinical staff and nationally recognized key opinion leaders, Tekton delivers excellence from trial design to patient recruitment, retention, and scientific rigor.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
